India and China Agree to Resolve Border Issues
On 4th July, 2024, External Affairs Minister S. Jaishankar and Chinese Foreign Minister Wang Yi agreed to enhance efforts through diplomatic and military channels to resolve remaining border issues in eastern Ladakh during a meeting in Astana.
Meeting Context
- The talks took place on the sidelines of the Shanghai Cooperation Organisation (SCO) summit in Astana, Kazakhstan.
- The discussions focused on addressing and resolving ongoing border disputes in eastern Ladakh.
Key Points
- Both ministers agreed to redouble efforts through diplomatic and military channels to achieve an early resolution of the border issues.
- India’s External Affairs Minister emphasized the importance of respecting the Line ....
Do You Want to Read More?
Subscribe Now
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Related Content
- 1 Golden Dome
- 2 Operation Gideon’s Chariots
- 3 USTR Special 301 Report Flags India’s IP Challenges
- 4 India-Belgium: Boosting Trade and Strategic Investments
- 5 India and Denmark Renew MoU on Clean Energy Cooperation
- 6 India Assumes APO Chairmanship for 2025–26
- 7 UK Transfers Sovereignty of Chagos Islands to Mauritius
- 8 US-Ukrainian Deal Grants Preferential Mineral Access to US
- 9 Algeria Joins New Development Bank
- 10 Nicaragua Withdraws from UNESCO

- 1 EAM’s Official Visit Strengthens India-Sri Lanka Ties
- 2 India-Russia Mutual Logistics Agreement Nears Conclusion
- 3 Russia-North Korea Pact
- 4 India Initiates WTO Arbitration against Australia
- 5 Amendments to International Health Regulations 2005
- 6 UN Global Supply Chain Forum Concludes Successfully
- 7 Summit on Peace in Ukraine
- 8 G7 Summit
- 9 BRICS Foreign Ministers meeting
- 10 Global Alliance Formed for Biopharmaceutical Resilience